July 3, 2025
Brick by Brick: A Brief Guide to Protecting Your Community’s Health with Direct Action
Publication
TAG’s Senior TB Project Associate, Erin McConnell, created this ‘zine about TAG for Pride 2025. It’s about fighting back, and goes over current threats, action items, and action steps on how to show up.

July 2, 2025
Community Webinar on Tests for TB and Drug-Resistance
Webinar / Presentation
Join us for a community webinar to break down the latest World Health Organization (WHO) guidelines and explore the most effective tools for diagnosing TB and drug resistance.

July 2, 2025
TAG to Honor Founding Member and Activist Dr. Richard Lynn as Third and Final Honoree at 2025 Research in Action Awards
Statement / Press
Treatment Action Group (TAG) is proud to announce Dr. Richard Lynn — scientist, activist, philanthropist, and founding member of TAG — as the third and final honoree for the 2025 Research in Action Awards (RIAA), to be held on October 20 at the Angel Orensanz Foundation in New York City.

July 1, 2025
Grant Officer
Treatment Action Group (TAG) is seeking a dynamic, highly motivated, and organized Grant Officer to support grant and fundraising efforts. This position will report to TAG’s Chief Operating Officer.

June 24, 2025
TAG to Honor Dr. Jeanne Marrazzo, Pioneering Infectious Disease Leader, at the 2025 Research in Action Awards
Statement / Press
Treatment Action Group (TAG) is proud to announce that Dr. Jeanne Marrazzo, MD, MPH, FACP, FIDSA, will be honored at the 2025 Research in Action Awards (RIAA) for her groundbreaking contributions to infectious disease research

June 17, 2025
TAG to Honor Gloria Reuben at 2025 Research in Action Awards
Statement / Press
Treatment Action Group (TAG) is proud to announce that Gloria Reuben — award-winning actress, singer, author, and longtime HIV/AIDS advocate — will be honored at the 2025 Research in Action Awards (RIAA) for her unwavering dedication to public health, activism, and the arts.

June 17, 2025
Tom Postilio & Mickey Conlon Named Event Chairs for TAG’s 2025 Research in Action Awards
Statement / Press
Treatment Action Group (TAG) is proud to announce that Tom Postilio and Mickey Conlon — renowned philanthropists, internationally acclaimed real estate leaders, and dedicated advocates for public health — will serve as Event Chairs for the 2025 Research in Action Awards (RIAA).

June 16, 2025
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry.

June 5, 2025
Treatment Action Group Statement on Termination of HIV Vaccine Research Funding
Statement / Press
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.

June 5, 2025
WEBINAR: TB Treatment’s New Frontier: Orienting Community to Long-Acting Injectables for TB
Webinar / Presentation
On June 5, 2025, TAG and WHO cohosted a webinar orienting people to long-acting injectables for TB treatment and prevention. Long-acting Injectables (LAIs) have the potential to revolutionize treatment for TB and other infectious diseases.

May 30, 2025
Perspectives of People with HCV Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
Publication
This publication discusses findings from two surveys conducted among end users and healthcare providers/policy makers to understand their perspectives on, and the facilitators and barriers to potential long-acting therapies for Hepatitis C virus (HCV) cure currently being developed by the LONGEVITY consortium, funded by the global health agency Unitaid.

May 21, 2025
An Ethical and Legal Crisis: Treatment Action Group (TAG) Statement on the Withholding of NIH Funding for HIV Clinical Research Networks
Statement / Press
TAG demands immediate action by the National Institutes of Health (NIH) to provide Congressionally appropriated and committed funding to the HIV clinical research networks (ACTG, HPTN, HVTN, IMPAACT).

May 20, 2025
2025 Comments Delivered at the WHO Director General’s TB Vaccine Accelerator Council
Letter / Comment
These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 3rd meeting of the WHO Director-General’s TB Vaccine Accelerator Council on May 20, 2025 in Geneva, Switzerland.

May 15, 2025
U.S. Funding Cuts Threaten 39 Research Sites in South Africa Putting Scientific Advancements and Hard Won Progress Against TB and HIV at Risk
Statement / Press
Lifesaving scientific research on prevention, testing, treatment and care for people living with HIV and tuberculosis (TB) in South Africa is under serious threat due to funding suspensions and grant terminations from the United States (US) government.

May 15, 2025
South Africa’s TB and HIV Research at Risk: A Call to Catalyze Urgent Action by Funders
Publication
Developed by TAG, Médecins Sans Frontières, and the South African Medical Research Council, this issue brief provides information about TB and HIV clinical trials and research programs impacted by U.S. government funding disruptions…

May 1, 2025
LONGEVITY Community Engagement: Perspectives of People with HCV and TB Lived Experience and Healthcare Providers on Potential Long-Acting Therapies
Webinar / Presentation
This webinar will provide a platform to learn about the findings from the Longevity HCV and TB end users and healthcare providers/policy makers surveys, and for community members, especially marginalized populations across the world, to engage with the researchers developing these Long-Acting Therapies.

May 1, 2025
NIH Advocacy Toolkit for HIV & TB Researchers
Publication
The Research Matters Advocacy Toolkit is a vital resource for researchers committed to advancing health equity and biomedical advocacy.

April 30, 2025
Hearing on Biomedical Research – Keeping America’s Edge in Innovation
Letter / Comment
Treatment Action Group (TAG) is issuing an urgent call to protect the integrity of biomedical research and public health.

April 27, 2025
Inside the Fight: A Day in the Life of TAG’s TB Team
What does TAG’s work look like in action? Here we step into a day in the life of our TB program co-directors, Mike Frick and Lindsay McKenna, to see how their advocacy for better TB research and policy — made possible by your support — are driving meaningful change to save lives and empower communities affected by TB.

April 24, 2025
Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals
Publication
TAG’s Magic Mountains of Debt: Sovereign Debt Crises as Critical Barriers to Ending TB and Investing in Sustainable Development Goals analyzes the impact  of sovereign debt in depressing investments in TB programs, services, and R&D in high-TB burden nations.

April 23, 2025
Speed-Up, Scale-Up TB Testing: A Two-Part Webinar Series Focused on the Asia-Pacific Region
Webinar / Presentation
TAG, APCASO,  and Diagnostics Equity Consortium (DEC) hosted a two-part webinar series exploring the evolving TB diagnostic landscape and strategies to increase TB testing coverage, with a specific focus on the South-East Asia and Western-Pacific regions.

April 23, 2025
Diagnostics Equity Consortium: Close the Deadly TB Testing Gaps in Asia-Pacific
Statement / Press
TAG is one of the endorsers of this Diagnostic Equity Consortium statement and call to action advocating for scaling up access to diagnostics to address the deadly gaps in TB testing.

April 11, 2025
Scoping Community Interventions to Support New TB Vaccine Introduction: From Grassroots Partnerships to Global Policymaking
Survey now extended until April 24! TAG, with support from Wellcome, is conducting a scoping exercise of community partners and interventions to support new TB vaccine readiness.

April 9, 2025
TAG Joins Call for the Resignation of HHS Secretary RFK, Jr., as a “Danger to the Public’s Health”
Statement / Press
Treatment Action Group (TAG) decries the vicious and inchoate attacks on HHS since the advent of the new administration, which have escalated significantly over the past week.

April 4, 2025
Tuberculosis Research at the National Institutes of Health – Saving Lives, Shrinking Costs, Fueling American Jobs and Innovation
Publication
This policy brief describes the crucial role NIH plays in supporting research on new products to prevent, diagnose, and cure TB. This research is especially important at a time when new forms of drug resistance are emerging globally, and rates of TB are rising in the U.S. With continued and increased funding, NIH can protect Americans from the growing threat of TB at home and abroad.